Your session is about to expire
← Back to Search
Cytokine
Interleukin-2 for Kidney Cancer
Phase 2
Waitlist Available
Research Sponsored by Blumenthal Cancer Center at Carolinas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Histologically confirmed renal cell carcinoma (RCC) that is metastatic or recurrent
Performance status: Karnofsky 80%-100%
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well low-dose interleukin-2 works in treating patients with kidney cancer that has spread or returned.
Who is the study for?
This trial is for adults over 18 with metastatic or recurrent kidney cancer who haven't had interleukin-2 therapy before. Participants must not have HIV, hepatitis B, systemic infections, psychiatric conditions affecting consent, ongoing bleeding sites, or certain heart and lung issues. They should not be pregnant or nursing and must agree to use effective contraception.Check my eligibility
What is being tested?
The study is testing the effectiveness of low-dose interleukin-2 in treating kidney cancer that has spread or come back. It's a Phase II trial aiming to see how well this treatment can stimulate white blood cells to fight cancer cells.See study design
What are the potential side effects?
Interleukin-2 may cause flu-like symptoms such as fever and chills, fatigue, nausea and vomiting; it can also affect normal blood counts leading to anemia or increased risk of infection and might cause low blood pressure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidney cancer has spread or come back.
Select...
I can carry out normal activities without assistance.
Select...
I do not have an infection that affects my whole body.
Select...
My liver function tests are within normal limits.
Select...
I do not have any current bleeding issues.
Select...
I am 18 years old or older.
Select...
I do not have a psychiatric condition that would prevent me from safely receiving immunotherapy.
Select...
My cancer has not spread to my brain or major nerves.
Select...
My kidney function is normal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Blumenthal Cancer Center at Carolinas Medical CenterLead Sponsor
3 Previous Clinical Trials
34 Total Patients Enrolled
Richard L. White, MDStudy ChairBlumenthal Cancer Center at Carolinas Medical Center
3 Previous Clinical Trials
34 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My kidney cancer has spread or come back.I can carry out normal activities without assistance.My lung function tests are above 65% of what's expected.I do not have an infection that affects my whole body.My treatment plan does not specify radiotherapy.My liver function tests are within normal limits.I do not have any current bleeding issues.My treatment plan does not specify hormone therapy.I am 18 years old or older.I do not have a psychiatric condition that would prevent me from safely receiving immunotherapy.My treatment plan does not specify surgery.My treatment plan does not specify chemotherapy.My heart stress test results are normal.My cancer has not spread to my brain or major nerves.My kidney function is normal.I have no other cancers except possibly skin cancer, cervical cancer not spread, or another type if my kidney cancer is the main concern.I do not need steroids for any condition.I am using effective birth control methods.I have never received interleukin-2 therapy.It has been over 28 days since my last kidney cancer treatment.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this a therapeutic option with minimal side effects?
"This is a Phase 2 trial, which suggests that while there is some evidence for the safety of this treatment, there are no studies yet demonstrating its efficacy. Our team at Power have given it a score of 2."
Answered by AI
Are there any vacancies in this research project for participants?
"The clinical trial mentioned is not currently looking for patients, based on the information provided by clinicaltrials.gov. This study was first posted on September 1st, 1995 and was most recently updated on December 18th, 2013. There are 432 other trials actively recruiting participants right now."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger